Shilpa Medicare Ltd Share Price

Q: What is the share price of Shilpa Medicare Ltd today?

Shilpa Medicare Ltd share price as on 22 Jan 2025 is ₹801.15

Pharmaceuticals - Indian - Formulations

NSE: SHILPAMED Small Cap ISIN: INE790G01031

As on 22 January 2025 at 18:16 IST

₹801.15

+ 1.75

(0.22%)

Sell Buy

Over 1 Month

2.72%

Over 6 Months

24.13%

Over 1 Year

147.61%

Over 3 Years

49.34%

Shilpa Medicare Ltd Summary

Close ₹ 801.15

Open ₹ 809.90

High ₹ 809.90

Low ₹ 782.75

Volume 2,07,498

Net Turnover (in ₹) ₹ 18,27,23,133.90

52Wk High ₹ 959.50

52Wk Low ₹ 316.10

52Wk High / Low

316.10

959.50

Shilpa Medicare Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 7,817.41

EPS (TTM) 4.82

Book Value (BV) 275.24

Div. Yield -

P/E (TTM) 180.87

Price/Book Value 2.90

Delivery % 49.50 %

Face Value 1

Key Ratios

PE Ratio 148.82

PB Ratio 1.87

EV to Sales 13.38

PEG Ratio -2.81

ROA 1.17

ROE 1.59

Debt-Equity 0.10

Net Profit Margin 10.93

Operating Profit Margin 37.06

Shilpa Medicare Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,159.77	1,067.51	1,159.77	931.27	924.85
Total Expenses	1,106.79	1,101.98	1,062.63	795.32	736.45
Profit Before Tax	54.34	-38.28	102.26	195.05	188.05
Profit After Tax	31.96	-30.97	60.58	146.20	154.56
Operating Profit after Depreciation	144.80	24.18	138.30	157.82	192.96

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	1,700.64	1,665.62	1,657.98	1,349.69	834.62
Total Non Current Assets	2,216.38	2,134.37	1,988.30	1,729.60	1,365.35
Total Current Assets	876.83	769.55	887.19	902.77	623.85
TOTAL ASSETS	3,093.20	2,903.93	2,875.50	2,632.37	1,989.20
Total Shareholder's Fund	1,808.69	1,783.28	1,822.19	1,478.67	1,329.36

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	135.34	179.92	105.13	46.93	124.38
Net Cash used in Investing Activities	-170.76	-232.27	-285.50	-404.28	-289.70
Net Cash used in Financing Activities	46.78	45.80	82.86	436.37	175.50

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	398.90	316.35	397.81	289.30	817.23
Total Expenses	350.36	359.08	379.14	252.03	600.35
Profit Before Tax	38.09	-58.28	27.49	90.21	212.34
Profit After Tax	26.94	-49.48	20.16	65.09	168.19
Operating Profit after Depreciation	65.80	-21.90	27.73	43.34	221.21

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	804.65	793.52	806.33	826.06	645.63
Total Non Current Assets	2,041.66	1,882.41	2,586.68	1,737.50	1,113.59
Total Current Assets	376.93	636.25	309.44	779.90	907.69
TOTAL ASSETS	2,418.58	2,518.66	2,896.12	2,517.39	2,021.28
Total Shareholder's Fund	2,142.72	2,117.58	2,065.67	1,637.83	1,453.42

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	8.03	2.08	173.87	69.63	129.79
Net Cash used in Investing Activities	155.82	-94.83	-378.97	-238.13	-295.10
Net Cash used in Financing Activities	-163.07	87.68	97.23	255.58	170.10

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	343.80	292.51	291.69	286.76	312.98
Total Expenses	258.18	222.43	221.77	221.61	254.59
Profit Before Tax	36.78	28.67	27.71	14.16	9.17
Profit After Tax	17.94	14.06	24.50	4.70	1.57
Operating Profit after Depreciation	90.61	79.52	72.41	67.09	60.20

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	129.68	96.12	59.36	63.98	74.61
Total Expenses	86.83	72.17	80.49	67.28	67.32
Profit Before Tax	50.64	40.69	-16.66	3.91	11.99
Profit After Tax	30.49	28.35	-18.35	2.70	6.60
Operating Profit after Depreciation	64.32	55.40	2.12	19.03	30.05

Shilpa Medicare Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 781.57

S2 763.73

S3 733.42

Pivot 811.88

R1 829.72

R2 860.03

R3 877.87

Moving Average

20 SMA 799.65

50 SMA 836.32

100 SMA 834.41

200 SMA 708.60

Shilpa Medicare Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 28 Sep 2022

AGM 28/09/2022 This is to inform that the 35' Annual General Meeting (AGM) of the Members of the Company will be held on Wednesday, the 28' September 2022 at 11.30. a.m. IST through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. (As per BSE Announcement Dated on 12/08/2022) Please find enclosed Notice convening the 35th Annual General Meeting (AGM) of the Company and Annual Report for the financial year 2021-2022 scheduled to be held on Wednesday, the 28th day of September 2022 at 11.30 A.M. IST at the Registered office of the Company through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities Exchange Board of India. (As Per BSE Announcement dated on 05.09.2022) Pursuant to Regulation 30 of the Listing Regulations, we are submitting herewith the details regarding the proceedings of 35th Annual General Meeting ('AGM') of the Company (enclosed herewith as Annexure) held on Wednesday, 28th September 2022 at 11.30 a.m. and concluded at 12.06 p.m. through Video Conferencing (VC) / Other Audio Visual Means (OAVM) at the Registered Office of the Company. The Insta-Poll commenced after the conclusion of AGM for 15 minutes. Summary of proceedings as required under Regulation 30, Part-A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations annexed hereto. (As per BSE Announcement Dated on 28/9/2022) In continuation of our letter dated 28th September 2022 regarding outcome of the 35th Annual General Meeting, please find enclosed newspaper publication of e-voting results of the 35th Annual General Meeting held on 28th September 2022 in 'businessline' - all edition (English) on 04th October 2022. (As Per BSE Announcement Dated 06.10.2022)

AGM Date: 29 Sep 2023

This is to inform that the Board of Directors at their meeting held on 01 September 2023 which commenced at 11.20 and concluded at 13:30 have inter alia consider and approved :- 1. The Annual Report for the Financial Year 2022-23. 2. Annual General Meeting of the Members of the Company: We are pleased to inform you that the 36th Annual General Meeting of Shilpa Medicare Limited is scheduled on Friday, the 29th day of September 2023 at 11:00 AM through video conferencing (VC)/ other audio visual means (OAVM) to transact the business(es) as set forth in the notice of the meeting. AGM Notice & Annual Report for the Fy 2022-23 (As Per BSE Announcement Dated on 05/09/2023) Outcome & Proceedings of the 36th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 29/09/2023)

AGM Date: 17 Sep 2024

We are pleased to inform you that the 37 Annual General Meeting of Shilpa Medicare Limited is scheduled on Tuesday, the 17 day of September 2024 at 10:00 AM through video conferencing (VC)/ other audio visual means (OAVM) to transact the business(es) as set forth in the notice of the meeting Pursuant to Regulation 30 read with Part A of Schedule III of SEBI(LODR) Regulations, submitting the proceedings of the 37th Annual General Meeting of the Company. (As Per BSE Announcement dated on 17.09.2024) Voting Results and Scrutinizer Report of 37th AGM (As Per BSE Announcement Dated on 19.09.2024)

EGM Date: 27 May 2022

By an order dated the 08th April 2022, the Bengaluru Bench of the Hon'ble National Company Law Tribunal, has directed to convene a meeting of Equity Shareholders, Trade Creditors and Secured Creditors of Shilpa Medicare Limited (Company) for the purpose of considering, and if thought fit, approving with or without modification, the Scheme of Amalgamation between INM Technologies Private Limited (Transferor Company) and Shilpa Medicare Limited (Transferee Company) and their respective Shareholders, Trade Creditors and Secured Creditors. In this regard, the meeting of the Equity Shareholders, Trade Creditors and Secured Creditors of the Company has been scheduled on 27 May 2022. Notice of the National Company Law Tribunal (Tribunal) Convened Meeting of the Equity Shareholders, Secured Creditors and Trade Creditors of the Company. (As per BSE Announcement Dated on 26/4/2022) In reference to the captioned subject, we hereby wish to inform that the NCLT Convened Meeting of the Equity Shareholders, Trade Creditors and Secured Creditors of Shilpa Medicare Limited on 27 May 2022. please find herewith the enclosed summary of the proceedings of meeting of the Equity Shareholders, Trade Creditors and Secured Creditors of the Company convened as per the directions of NCLT as Annexures I, II and III respectively. (As Per BSE Announcement Dated on 27.05.2022) Please find enclosed the Scrutinizer's Report dated 30' May 2022 for the Equity Shareholders meeting of Shilpa Medicare Limited convened by the Hon'ble National Company Law Tribunal ('NCLT'), Bengaluru Bench held on Friday the 27th day of May 2022 at 9.00 a.m. through Video Conference ('VC')/ Other Audio-Visual Means ('OAVM') at 'Shilpa House', # 12-6-214/A-1, Hyderabad road, Raichur - 584 135, Karnataka for the purpose of sanctioning the Scheme of Amalgamation between INM Technologies Private Limited (Transferor Company) and Shilpa Medicare Limited (Transferee Company). (As Per BSE Announcement Dated on 30/05/2022)

Shilpa Medicare Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Shilpa Medicare Ltd	₹799.45	₹7,817.89
Sun Pharmaceuticals Industries Ltd	₹1,761.80	₹4,22,714.84
Divis Laboratories Ltd	₹5,818.40	₹1,54,460.24
Cipla Ltd	₹1,427.30	₹1,15,270.75
Dr Reddys Laboratories Ltd	₹1,288.45	₹1,07,511.36
Torrent Pharmaceuticals Ltd	₹3,157.60	₹1,06,862.73

Shilpa Medicare Ltd News

Shilpa Medicare gets European authority nod for Tadalafil drug

Shilpa Medicare informed that it has received marketing authorization from Portugal, Europe, for Tadalafil Orodispersible Films, 20 mg.

10 Jan 2025, 02:45 pm

Shilpa Medicare gets GMP approval for Hyderabad facilities

Shilpa Medicare informed that it's Unit 4, Jadcherla, and Unit 7, Nacharam in Hyderabad, Telangana had undergone a GMP inspection by Ministry of Health, Belarus for GMP certification from the Eurasian Economic Union in October 2024.

27 Dec 2024, 12:19 pm

Shilpa Medicare's Unit IV and Unit VII secures Eurasia GMP approval

27 Dec 2024, 11:36 am

Shilpa Medicare gets GMP certification for Hyderabad Facility

Shilpa Medicare has announced the successful completion of an inspection conducted by the European Medicines Agency (EMA) at its Unit 7 in Nacharam, Hyderabad, Telangana.

20 Dec 2024, 03:14 pm

Shilpa Medicare JV gets USFDA approval for IMKELDI drug

Shilpa Medicare said that its joint venture (JV), Oncosol, along with its partner Shorla Oncology, has received US Food and Drug Administration (USFDA) approval for IMKELDI (imatinib oral solution) to treat leukemia and other cancers.

27 Nov 2024, 03:47 pm

Shilpa Medicare Ltd Stock Analysis

Annual revenue for Shilpa Medicare Ltd increased by 26.10% to ₹398.90 crore in FY 2024 from ₹316.35 crore in FY 2023.
Annual Net Profit for Shilpa Medicare Ltd decreased by 154.44% to ₹26.94 crore in FY 2024 from ₹-49.48 crore in FY 2023.
Promoter Shareholding in Shilpa Medicare Ltd decreased by 0.14% in the most recent quarter, from 44.39% in June 2024 to 44.33% in September 2024.
Shilpa Medicare Ltd delivered a 1-year return of 147.61% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Shilpa Medicare Ltd share price moved up by 0.22% from its previous close of INR ₹799.40. The latest Shilpa Medicare Ltd share price is INR ₹801.15.
Shilpa Medicare Ltd share price today has been at a low of 782.75 and a high of 809.90. Over the past 52 weeks, the Shilpa Medicare Ltd share price has seen a low of 316.10 and a high of 959.50.